Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States | Orphanet Journal of Rare Diseases | Full Text

Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States | Orphanet Journal of Rare Diseases | Full Text

Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States

There are limited data on economic aspects of the genetic variant of chronic obstructive pulmonary disease (COPD) in the context of the more prevalent form of COPD. The objective of this study was to isolate t...

Authors:Jan Sieluk, Julia F. Slejko, Henry Silverman, Eleanor Perfetto and C. Daniel Mullins

Citation:Orphanet Journal of Rare Diseases 2020 15:260

Content type:Research

 

Published on: 23 September 2020

• ViewFull Text
 
• ViewPDF